Paper published in Clinical Cancer Research
Combined EZH2 inhibition and Ikaros degradation leads to enhanced anti-tumor activity in diffuse large B-cell lymphoma. Tong K, Yoon S, Isaev K, … Kridel R. Clinical Cancer Research, 2021.
[Read More]